Literature DB >> 7957349

Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia.

M Banyai1, G Lupattelli, S R Li, S Pongratz, Q Yang, P Böck, P Angelberger, I Virgolini.   

Abstract

The binding of radiolabelled lipoproteins, iodine-123-labelled low-density lipoprotein (LDL) and indium-111-labelled LDL, to peripheral blood mononuclear cells (MNCs) was compared in normolipaemic subjects and in patients with heterozygous familial hypercholesterolaemia (FH). 123I-LDL and 111In-LDL binding to MNCs exhibited high-affinity, highly specific, time- and temperature-dependent binding reaching saturation at concentrations above 50 nM. The number of LDL binding sites (Bmax) was significantly (P < 0.01) lower in FH patients (P < 0.001; 123I-LDL: Bmax 279 +/- 44 ng protein/10(8) MNCs; 111In-LDL: Bmax 309 +/- 43 ng protein/10(8) MNCs) as compared with controls (123I-LDL: Bmax 2874 +/- 246 ng protein/10(8) MNCs; 111In-LDL: Bmax 3145 +/- 339 ng protein/10(8) MNCs). The corresponding dissociation constants (Kd) were 16 +/- 8 nM for 123I-LDL and 12 +/- 6 nM for 111In-LDL in healthy volunteers (123In-LDL vs 111In-LDL, P < 0.05). In FH patients, the Kd values were 20 +/- 8 nM for 123I-LDL and 16 +/- 6 nM for 111In-LDL (P < 0.05 vs controls for both 123I-LDL and 111In-LDL). 111In-LDL binding to MNCs was inhibited (IC50) by 30 +/- 8 nM in healthy controls and 38 +/- 12 nM in FH patients (P < 0.05). 123In-LDL binding to MNCs was inhibited (IC50) by 34 +/- 8 nM in healthy controls and 46 +/- 10 nM in FH patients (P < 0.05). Taken together, these results suggest a reduced number of LDL receptors expressed on MNCs from FH patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957349     DOI: 10.1007/BF00285585

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitro.

Authors:  I Virgolini; P Angelberger; G Lupattelli; S R Li; J Pidlich; E Molinari; H Sinzinger
Journal:  Int J Rad Appl Instrum B       Date:  1991

2.  Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane.

Authors:  E Koller; F Koller; B R Binder
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 5.  How LDL receptors influence cholesterol and atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Sci Am       Date:  1984-11       Impact factor: 2.142

6.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

7.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

Authors:  P L Canner; K G Berge; N K Wenger; J Stamler; L Friedman; R J Prineas; W Friedewald
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

8.  Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.

Authors:  I Virgolini; S Li; Y Qiong; E Koller; M Banyai; P Angelberger; H Sinzinger
Journal:  Arterioscler Thromb       Date:  1993-04

9.  Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein.

Authors:  I Virgolini; P Angelberger; S R Li; F Koller; E Koller; J Pidlich; G Lupattelli; H Sinzinger
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

10.  Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes.

Authors:  Y K Ho; S Brown; D W Bilheimer; J L Goldstein
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more
  1 in total

1.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.